Summary
A 16-year-old boy with persistent hyperglycaemia (approximately 16 mmol/l in the fasting state) and acanthosis nigricans had insulin resistance and received daily up to 2 800 U of short-acting, soluble, highly purified porcine insulin. The number and affinity of insulin receptors were markedly decreased. No significant insulin binding to IgG could be detected. Immunoreactive insulin varied between 1344 and 2400 mU/l. Endogenous insulin secretion and proinsulin levels were grossly elevated in the fasting state (C-peptide 2.2–3.5 pmol/ml; proinsulin approximately 1 pmol/ml). After an oral glucose tolerance test and intravenous arginine infusion, B cell hypersecretion was confirmed. The molar ratio of C-peptide to immunoreactive insulin, normally approximately 7, was about 0.3, clearly indicating that most of the immunoreactive insulin was exogenous. The molar ratio of proinsulin to C-peptide, which is about 0.05 in fasting control subjects, was 0.23–0.45, clearly showing that too high a proportion of proinsulin was being secreted. This may indicate that the constant hyperstimulation of the B cell leads to reduced conversion of proinsulin to insulin. Immunoreactive glucagon levels were within normal limits fasting but were above normal after intravenous arginine infusion. Thus, in this case of diabetes with acanthosis nigricans, the severe insulin resistance, probably caused by a receptor defect, was associated with markedly increased B cell function.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bar RS, Muggeo M, Kahn CR, Gorden Ph, Roth J (1980) Characterization of insulin receptors in patients with the syndromes of insulin resistance and acanthosis nigricans. Diabetologia 18: 209–216
Bar RS, Muggeo M, Roth J, Kahn CR, Havrankova J, Imperato-McGinley J (1978) Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: Evidence for a postreceptor defect. J Clin Endocrinol Metab 47: 620–625
Christiansen AH (1973) Radioimmunoelectrophoresis in the determination of insulin-binding to IgG. Methodological studies. Horm Metab Res 5: 147–154
Colle M, Doyard P, Chaussain JL, Battin J, Job JC (1979) Acanthosis nigricans, hirsutisme et diabetes insulino-resistant. Arch Franc Pediatr 36: 518–523
De Meyts P, Roth J (1975) Cooperativity in ligand binding: a new graphic analysis. Biochem Biophis Res Comm 66: 1118–1126
Flier JS, Young JB, Landsberg L (1980) Medical Intelligence. Familial insulin resistance with acanthosis nigricans, acral hypertrophy, and muscle cramps. N Eng J Med 303: 970–973
Gambhir KK, Archer JA, Carter E (1978) Characteristics of human erythrocyte insulin receptors. Diabetes 27: 701–708
Heding EG (1971) Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7: 10–19
Heding EG (1972) Determination of total serum insulin in insulintreated diabetics patient. Diabetologia 8: 260–266
Heding EG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Heding EG (1977) Specific and direct radioimmunoassay for human proinsulin in serum. Diabetologia 13: 467–474
Heding EG, Kasperska-Czyzykowa T (1980) C-peptide and proinsulin after oral glucose. Acta Med Scan Suppl 639: 33–36
Jørgensen KH, Larsen UD (1980) Homogeneous mono-125Iinsulins. Preparation and characterization of mono-125I-(Tyr A 14)and mono-125I-(Tyr A 19)-insulin. Diabetologia 19: 546–554
Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J (1976) The syndrome of insulin resistance and acanthosis nigricans. N Eng J Med 294: 739–745
Kahn CR, Podskalny JM (1980) Demonstration of a primary (genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans type A. J Clin Endocrinol Metab 50: 1139–1141
Mendenhall EN (1950) Tumor of pineal body with high insulin resistance. J Indiana Med Assoc 43: 32–36
Pavia C, Albaran IM, Nosas R, Martin MR, Casmitjana R, Potau N (1980) {ie12-01}Sindrome “X” en el varon? (acantosis nigricans, resistencia a la insulina, macrogenitosomia) V Congreso Nacional de Diabetes. Sevilla 2–3 Noviembre. Spain. p 61 (Abstract)
Perez Corral F, de la Viña S, Carbó ME, Barrio R, Yturriaga R, Perez Maceda B, Alonso M, Serrano Rios M (1980) Rabson syndrome: Model of insulin resistance due to decreased number and affinity of insulin receptors in erythrocytes. Diabetologia 19: 36 (Abstract)
Podskalny JM, Kahn CR (1982) Cell culture studies on patients with extreme insulin resistance. I. Receptor defects on cultured fibroblasts. J Clin Endocrinol Metab 54: 261–268
Podskalny JM, Kahn CR (1982) Cell culture studies on patients with extreme insulin resistance. II. Abnormal biological responses in cultured fibroblasts. J Clin Endocrinol Metab 54: 269–275
Rechler MM, Podskalny JM (1976) Insulin receptors in cultured human fibroblasts. Diabetes 25: 250–255
Serrano Ríos M, de la Viña S, Barrio R, Carbó ME, Yturriaga R, Perez Maceda B, Alonso M, Perez Corral F (1981) Two models of insulin resistance studied by insulin binding to erythrocytes. In: Andreani D, De Pirro R, Lauro R, Olefsky J, Roth J (eds) Serono Symposium n∘ 41, Current Views on Insulin Receptors. Academic Press, London, New Yerk, pp 579–585
Taylor SI, Samuels B, Roth J, Kasuga M, Hedo JA, Gorden Ph, Brasel DE, Pokora T, Engel RR (1982) Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance. J Clin Endocrinol Metab 54: 919–930
Turker WR, Klink D, Goetz F, Zalme E, Knowles HC (1964) Insulin resistance and acanthosis nigricans. Diabetes 13: 395–399
West RJ, Lloyd JK, Turne WML (1975) Familial insulin-resistant diabetes, multiple somatic anomalies, and pineal hyperplasia. Arch Dis Child 50: 703–705
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ríos, M.S., de la Viña, S., Carbó, M.E. et al. Pancreatic A and B cell hyperfunction in the mendenhall syndrome. Diabetologia 25, 8–12 (1983). https://doi.org/10.1007/BF00251888
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00251888